DIG-RHD: Digoxin Effective in Rheumatic Heart Disease
The DIG‑RHD trial, presented at ACC 2026, randomized 1,759 patients with symptomatic rheumatic heart disease in India to digoxin or placebo. Over a median 2.1‑year follow‑up, digoxin achieved a 4.1‑percentage‑point absolute reduction in the composite of all‑cause death or new‑onset/worsening heart failure (41.4% vs 35.5%; HR 0.82). The benefit was driven by fewer heart‑failure hospitalizations, while overall mortality remained unchanged. Conducted for under $600,000, the study highlights an inexpensive, widely available therapy for a disease that disproportionately affects low‑income populations.
IPLEDGE Risk Evaluation and Mitigation Strategy (REMS)
The FDA approved a set of modifications to the iPLEDGE Risk Evaluation and Mitigation Strategy on February 9, 2026, aimed at easing administrative burdens while preserving safety for isotretinoin users. Key changes include allowing home pregnancy tests during and after...
Hims & Hers Says Limited Data Stolen in Social Engineering Attack
Hims & Hers disclosed a sophisticated social‑engineering breach that compromised its third‑party customer‑service platform from February 4‑7, 2026. Hackers accessed service tickets, exposing customer names and email addresses, but the firm confirmed that electronic medical records and provider communications were untouched....
Screening and Treatment for Chronic Kidney Disease in Heart Disease Patients Needs to Be Expanded
A new multinational INTERASPIRE study of 4,548 coronary artery disease (CAD) patients found chronic kidney disease (CKD) is under‑detected and undertreated. Relying solely on eGFR missed about half of CKD cases, while adding urinary albumin/creatinine ratio (UACR) captured the majority....
Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)
The FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) now requires manufacturers to supply prepaid mail‑back envelopes (MBEs) for safe opioid disposal, with pharmacies able to order them starting March 31 2025. The REMS education program, funded by unrestricted grants, offers...
Low-Cost, Single Sample Blood Test Detects Different Cancers, Liver Disorders, and Other Diseases
UCLA researchers unveiled MethylScan, a low‑cost blood test that analyzes cell‑free DNA methylation to detect multiple cancers and liver disorders in a single sample. By using methylation‑sensitive enzymes to strip away background DNA, the assay reduces sequencing needs to about...
Court Strikes HRSA 340B Policy Restricting Initial Hospital Drug Purchases Through GPOs
On March 31, a U.S. District Court in Washington, D.C. vacated the Health Resources and Services Administration’s 2013 rule that barred disproportionate‑share hospitals from making initial outpatient drug purchases through both the 340B Drug Pricing Program and a group purchasing...
AHA Podcast: The CMO’s Role in Better Outcomes
The American Hospital Association podcast spotlights Chief Medical Officer Phillip Chang of CommonSpirit Health, who discusses how CMOs are reshaping health‑care delivery. He emphasizes the need for robust data measurement and quality metrics to drive better patient outcomes. Chang also...
The $4B Bifurcation: Why Digital Health Funding Is Consolidating Around the Mega-Deal
U.S. digital health funding surged to $4.0 billion in Q1 2025, spread across 110 deals with an average size of $36.7 million, the highest since late 2021. Nearly 60% of that capital was captured by just 12 companies securing $100 million‑plus mega deals, including Whoop’s...
Pair of New Health Care Initiatives Formed
The Los Angeles Area Chamber of Commerce, together with its CEO Council, launched a $350,000 employer‑led workforce initiative called “A Paradigm Shift” to train students for high‑demand jobs, beginning with health care. Partnering with the Los Angeles Community College District,...
CMS: More Flexible Plan Choices for Medicare Beneficiaries
CMS announced updates to Medicare Advantage and Part D plans for 2027, aiming to simplify star ratings, add a depression‑screening measure, and reduce regulatory burdens. The agency will streamline the star‑rating measure set, keep the Diabetes Care‑Eye Exam metric, and drop...
Data Platform Unifies Blood Cancer 'Omics' And Clinical Data to Accelerate Discovery
Scientists from St. Jude Children’s Research Hospital, the American Society for Hematology and the Munich Leukemia Laboratory launched the ASH HematOmics (ASHOP) platform, uniting genomics, transcriptomics and clinical data from 5,960 blood‑cancer patients. The open resource combines whole‑genome and whole‑transcriptome...
Detecting Multiple Cancers and Other Diseases From a Single Blood Sample
UCLA researchers introduced MethylScan, a blood test that reads cell‑free DNA methylation to flag multiple cancers and liver diseases in a single assay. In a cohort of 1,061 participants the test achieved 98% specificity, detecting about 63% of cancers overall...
Under-the-Skin Tepezza Comparable to Infused Version in Key Study, Amgen Says
Amgen announced that its subcutaneous on‑body injector version of Tepezza, called Tepezza OBI, met both primary and key secondary endpoints in a late‑stage trial, showing 77% of patients achieved a meaningful reduction in eye bulging. The efficacy was comparable to...
2026 Perspectives in Private Equity: Health Care & Life Sciences
Private equity in health care and life sciences faces a turbulent 2026 as the new administration rolls back ACA subsidies and implements the One Big Beautiful Bill Act, slashing Medicaid spending by roughly $800 billion over the next decade. The loss...
VDyne Secures FDA Nod to Start Pivotal Trial for Tricuspid Valve
VDyne received FDA approval for an investigational device exemption to launch its pivotal TRIVITA trial of a transcatheter tricuspid valve replacement system. The study will assess safety and efficacy in patients with severe symptomatic tricuspid regurgitation, a condition affecting roughly...
FDA Warns Resin Change May Have Caused Tubing Danger
The FDA issued an urgent alert that B. Braun’s recent tubing‑resin change in its Streamline Airless System and B3 Low Volume hemodialysis bloodlines is causing small air bubbles to adhere inside the arterial line. These bubbles trigger machine alarms, halt treatment...
FDA Public Meeting: FDA-Led Patient-Focused Drug Development Meeting for Nonhealing Chronic Wounds - 08/25/2026
On August 25, 2026 the FDA will host a hybrid Patient‑Focused Drug Development meeting dedicated to non‑healing chronic wounds. The public session runs from 10 a.m. to 4:30 p.m. ET and combines a virtual webcast with an in‑person gathering at the White Oak Campus....
Proposed FDA Budget Sets Makary up to Boost US Biotech
The White House’s FY budget proposes a sizable increase for the FDA, positioning Dr. Robert Makary to spearhead regulatory reforms aimed at accelerating U.S. biotech development. The plan includes policy changes that would shorten clinical‑trial timelines, lower fees for early‑stage...
What Are Rural Healthcare IT Priorities In a Changing Funding Landscape?
Rural healthcare organizations are bracing for reduced Medicaid funding while eyeing the $10 billion‑per‑year Rural Health Transformation Program. Tight cash reserves are driving IT leaders to prioritize short‑term resilience, cost‑cutting measures and rapid‑ROI technologies such as AI‑enabled documentation, cloud migration, and...
CMS Proposes New Transparency Measures to Strengthen Oversight of Hospice Providers
The Centers for Medicare & Medicaid Services (CMS) has proposed a rule that adds unannounced site visits, revocations of non‑compliant hospices, and a new Medicare.gov icon to flag providers that fail quality‑reporting standards. A publicly available scoring system will evaluate...
Can Medicinal Cannabis Help Kids’ Autism, ADHD or Tourette’s? Here’s What We Know so Far
Interest in medicinal cannabis for children with autism, ADHD and Tourette's has grown, prompting the Australian Therapeutic Goods Administration to confirm that doctors are prescribing it for these conditions. While parents hope it could reduce reliance on stimulants, antidepressants and...
Global Cohort Data Bolster Confidence in Dolutegravir for Pediatric HIV Care
A new analysis presented at CROI 2026 used International Epidemiology Databases to Evaluate AIDS (IeDEA) data from Africa, Asia‑Pacific, and Latin America, covering over 90% of the world’s children with HIV. The study found that dolutegravir initiates modest early weight gain...
Experts Warn MA Auto Enrollment Would Limit Choice, Raise Costs
Health policy experts are warning that the Centers for Medicare & Medicaid Services is exploring automatic enrollment of Medicare beneficiaries into Medicare Advantage (MA) plans. They argue the move could curtail seniors' ability to choose alternative coverage and drive up...
New Technique Identifies Proteins that Trigger Immune Responses in Transplants and Implants
Mayo Clinic researchers introduced a new method called the Ratio of Immunogenicity (ROI) to identify proteins that provoke strong immune responses. By measuring protein abundance and immune activation, the ROI ranks proteins from most to least immunogenic, revealing that mitochondrial...
Startup Approved to Let AI System Prescribe Psychiatric Medication
Legion Health, a San Francisco startup, received Utah regulatory approval to let its AI chatbot renew psychiatric prescriptions for a limited set of antidepressants such as Prozac and Zoloft. The system can only prescribe drugs previously authorized by a human...
Holland Foundation Looks to Expand Vision-Saving Transplants
The Holland Foundation for Sight Restoration is scaling its Cincinnati Protocol for ocular surface stem‑cell transplantation by establishing “centers of excellence” and expanding surgeon education. To date, five centers—from Cincinnati to UC Irvine, Virginia Eye Consultants, and Massachusetts Eye and...
A Key Antitrust Case Against Providers, Plus the Marriage of Patient Experience and AI
In a recent HFMA podcast, senior editor Erika Grotto and FinThrive’s Jonathan Wiik dissect a high‑profile antitrust lawsuit targeting alleged price‑fixing among hospital providers. The discussion also explores how artificial intelligence can be woven into the patient‑experience journey to boost...
AED Algorithm Could Improve Location of Lifesaving Devices
Cedars‑Sinai researchers have created a geospatial algorithm that identifies clusters of sudden cardiac arrests and recommends optimal public AED locations within 200 meters of those hotspots. The model analyzed incidents from 2012‑2023 in Ventura County, California, and Multnomah County, Oregon,...
HL7 Launches Device Interoperability Implementation Community
Health Level Seven International (HL7) has launched the Caliper FHIR Accelerator implementation community to accelerate real‑world exchange of data from medical and personal health devices. The multi‑stakeholder group builds on the Gemini Device Interoperability Program and will use FHIR standards,...
About 80% of Breast Cancer Biopsies Turn Out Benign. New Imaging Tool Promises Clearer Diagnoses and Fewer Biopsies
About 80% of breast biopsies in the United States turn out benign, prompting calls for less invasive diagnostics. Researchers have developed a hand‑held device that merges traditional ultrasound with diffuse optical tomography (DOT), which maps blood hemoglobin and oxygen levels...
Study Outlines Life-Enhancement Paths for Those in Long-Term Care Facilities
A University at Buffalo mixed‑methods study observed 20 life‑enhancement sessions in a Canadian long‑term care facility, identifying how activity design and delivery affect resident engagement. Researchers tracked self‑initiative, social interaction, emotional expression, and distractions, finding that interactive, music‑rich, facilitator‑led activities...
FDA Drug Info Rounds Video
The FDA’s Center for Drug Evaluation and Research has launched the Drug Info Rounds video series, a free on‑demand library that educates health‑care professionals on drug safety, regulatory processes, and compliance. The series covers topics such as MedWatch reporting, Medication...
AI-Written Code Can Beat Humans at Biomedical Analysis, some Studies Find. What Does that Mean for the Field?
A recent study published in Cell Reports Medicine shows that large language models can generate biomedical analysis code that matches or exceeds expert performance. Junior researchers, including a graduate student and a high‑school student, used simple prompts to produce accurate...
Behind The Scenes: How Smart Storage Keeps Healthcare Running Smoothly
Smart storage systems are becoming essential in healthcare facilities, safeguarding medications, patient records, and equipment through locked cabinets and digital tracking. Organized layouts and frequency‑based shelving cut staff search time, allowing more focus on patient care. Real‑time inventory platforms alert...
Two Breaches, One Quarter: Valley Family Health Care’s Challenging Start to 2026
Valley Family Health Care (VFHC) disclosed a TriZetto Provider Solutions breach on Jan. 12 that exposed the personal and health‑insurance data of 4,300 patients. In March, the cyber‑crime group Insomnia listed VFHC on a dark‑web leak, claiming more than one million...
Placental Abruption Raises Offsprings’ Risk for Heart Disease, Death
A new study published in the Journal of the American Heart Association finds that children born after a placental abruption face a dramatically higher risk of cardiovascular disease and death by age 28. The analysis of 2,949,992 singleton pregnancies from...
Catalyst MedTech Establishes Full Access Neurology Solution for Brain PET Implementation in the U.S.
Catalyst MedTech announced the nationwide rollout of its Full Access Neurology solution, a bundled offering that enables health systems to deploy dedicated brain PET imaging without large capital outlays. The platform combines CareMiBrain‑powered scanners, quantification software, service and maintenance, and...
A Target for Ameliorating Post-Operative Delirium
Researchers identified the chromatin remodeler RUVBL2 as a key driver of metabolic reprogramming in microglia that underlies post‑operative delirium in aged rats. Suppressing RUVBL2 reversed the glycolytic shift, boosted ATP production, reduced stress‑granule accumulation, and restored performance on Barnes maze...
Inside The Sterile Barrier: How Containment Protects Quality In Healthcare
Healthcare providers rely on sterile barrier systems to keep medical devices and products free from microbial contamination. By integrating robust packaging, sealing methods, and controlled storage, these barriers protect patient safety throughout the product lifecycle. Mapping each handling, transport, and...
Arizona Cardiology Practice Paying $3.85M to Resolve Lawsuit After Data Breach
Cardiovascular Consultants, a Phoenix cardiology practice owned by Fresenius Medical Care, agreed to pay $3.85 million to settle a class‑action lawsuit stemming from a September 2023 data breach. The breach potentially exposed personal data of 500,000 patients and 200 employees, including Social...
Lost In The Hallway: Why Navigation Stress Matters In Healthcare Facilities
Healthcare facilities often suffer from confusing layouts, poor signage, and inadequate wayfinding tools, leading to heightened patient stress and missed appointments. The article highlights how clear signage, color‑coded cues, and consistent design can streamline navigation. It also emphasizes the role...
Corewell Health Sees Big Benefits From Its Remote Patient Monitoring Investments
Corewell Health, a Michigan nonprofit system, partnered with Cadence to embed remote patient monitoring (RPM) into primary‑care workflows for hypertension, diabetes and heart‑failure patients. The program achieved over 80% patient engagement and delivered measurable clinical gains in four months, including...
BIO’s Comments for USTR Report Highlight Global Threats to Intellectual Property
The Biotechnology Innovation Organization (BIO) submitted comments to the USTR’s 2026 Special 301 Report urging stronger global enforcement of intellectual‑property (IP) rights for biotech. BIO argues that weak IP protections in markets such as Colombia, Russia and Brazil create barriers...
Vitamin D Shows Potential to Reduce Long COVID Symptoms: JoAnn E. Manson, MD, MPH, DrPH
A recent randomized VIVID trial examined vitamin D₃ supplementation in newly diagnosed COVID‑19 patients and found a non‑significant trend toward fewer long‑COVID symptoms at eight weeks. While primary outcomes such as healthcare utilization were unchanged, researchers noted that delayed treatment...
Other News to Note for April 6, 2026
Jiangsu and Shanghai Hengrui have patented selective Nav1.8 sodium‑channel blockers that show pre‑clinical analgesic efficacy with fewer side effects. New hematopoietic stem‑cell research links chronic inflammation to early leukemic transformation, identifying inflammatory pathways as therapeutic targets. Infinimmune presented pre‑clinical data...
Biopharma Financings Nearly Double Vs. 2025 to $25.1B
Biopharma financing nearly doubled year‑over‑year, reaching about $25.1 billion, fueling a wave of early‑stage research. Jiangsu and Shanghai Hengrui patented novel Nav1.8 sodium‑channel blockers aimed at chronic pain relief. New hematopoietic stem‑cell studies link inflammation to the earliest stages of leukemia,...
Regulatory Actions for April 6, 2026
BioWorld’s April 6, 2026 regulatory snapshot aggregates the day’s key FDA and global health authority actions across biopharma, medical technology, and diagnostics. The page links to data snapshots, special reports, infographics and trend analyses covering topics such as mRNA vaccine research, GLP‑1...
St. Luke’s Stays on Track with Massive Expansion
St. Luke's Medical Center announced it will proceed with a massive expansion despite rising costs from the Middle East crisis. The group plans to break ground on a new 500‑bed Aseana hospital in Parañaque costing about P18 billion (≈$324 million) with an...
Over-the-Counter Medication Abortion? These Researchers Say It Would Be Safe
Researchers at UCSF surveyed 168 patients about a prototype over‑the‑counter medication abortion kit, finding 88% concordance between self‑assessment and clinician eligibility. The study, published in JAMA Internal Medicine, suggests patients can reliably determine suitability for mifepristone‑misoprostol regimens without a prescriber....